Recent studies suggest that homeostasis of lipid metabolism is crucial for the function of various immune cells. Oxygenated derivatives of cholesterol (oxysterols) are well-known regulators of lipid metabolism and have diverse functions, such as inhibition of cholesterol synthesis, efflux of intracellular cholesterol, synthesis of cholesterol esters, and activation of liver X receptors (LXRs). In this review, we introduce novel roles of the oxysterol receptors LXRs in the immune system, including regulation of inflammatory responses, T cell expansion, immunoglobulin production, and antitumor responses. We also discuss lipid-mediated signaling as a potential target for treatment of immune diseases.
Introduction
Oxygenated derivatives of cholesterol (oxysterols), such as 7-a-hydroxycholesterol, 7-ketocholesterol, 24S-hydroxycholesterol, 25-hydroxycholesterol, 27-hydroxycholesterol, and 22R-hydroxycholesterol, are produced from cholesterol through auto-oxidation (1) . In addition, enzymatic processes have been reported to occur during oxysterol production. For example, cholesterol 7-a-hydroxylase converts cholesterol to 7-a-hydroxycholesterol. The enzymes 24S-hydroxylase, 25-hydroxylase, and 27-hydroxylase contribute to biosynthesis of 24S-hydroxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol, respectively, starting with cholesterol (2, 3) . However, oxysterols are present in very low concentrations in plasma, and for that reason, it has been difficult to investigate their biological functions in vivo for many years. In the 1990s, Mangelsdorf and colleagues employed an in vitro binding assay to reveal that oxysterols are ligands for the liver X nuclear receptor (LXR) (4, 5) . Currently, 25-hydroxycholesterol, 27-hydroxycholesterol, 22R-hydroxycholesterol, and 24S, 25-epoxycholesterol are thought to be naturally occurring ligands bound by LXR.
LXRa (NR1H3) and b (NR1H2) were identified from a liver cDNA library in 1994 and 1995. Further studies demonstrated that LXRa expression is restricted to liver, lung, spleen, adipose tissue, kidney, intestine, and adrenal glands. In contrast, LXRb expression is ubiquitous. As summarized in Table 1 , murine leukocytes (excluding macrophages) predominantly express LXRb but not LXRa (6, 7); however, human CD4 T cells and B cells express both LXRa and LXRb (Table 1) (8, 9) . This discrepancy can be explained by an autoregulatory loop involving LXRa: namely, promoter of the human LXRa gene, but not of the murine LXRa gene, has an LXRa binding region, and binding of LXRa to its own promoter induces transcription of the gene (10) .
Recently, Chen et al. used triple-knockout mice deficient in cholesterol 24S-hydroxylase, 25-hydroxylase, and 27-hydroxylase to show that these naturally occurring oxysterols act as ligands for LXR in vivo (11) . Interestingly, recent studies of LXR-null mice demonstrated that LXR activation via oxysterols plays a role in regulating the innate and adaptive immune responses. Mice lacking LXRs exhibit defective clearance of intracellular bacteria and apoptotic cells (12) (13) (14) , age-dependent lymphoid hyperplasia, and systemic autoimmune diseases (6, 12) , as well as increased antitumor responses (15) . In addition to LXR activation, however, oxysterols have LXR-independent biological functions, such as inhibition of HMG CoA reductase (16) (17) (18) and synthesis of cholesterol esters (19) (20) (21) (22) . In the following section, we will discuss how oxysterols contribute to the regulation of the immune response.
Roles of LXR activation for macrophage functions in innate and adaptive immunity
Macrophages play a crucial role in innate immunity against bacterial infection. Joseph et al. reported that activation of LXR in macrophages with a synthetic ligand represses the expression of proinflammatory genes such as interleukin (IL)-6, IL-1b, COX-2, and iNOS in response to bacterial (23) . This LXR-dependent repression of proinflammatory gene expression in macrophages is mediated through the suppression mechanism known as transrepression (24, 25) . In contrast to these findings, upon LPS stimulation in the absence of synthetic LXR ligands, the levels of proinflammatory gene expression induced in LXRab q/q and LXRab -/-macrophages were comparable (23) . These results suggest that basal LXR activation via endogenous oxysterols in macrophages is insufficient to repress inflammatory responses against pathogens. Nevertheless, LXRa -/-but not LXRb -/-mice show high susceptibility to the intracellular pathogen Listeria monocytogenes (LM) (14) . This susceptibility is due to the fact that LXRa -/-macrophages fail to express the scavenger receptor SPa/AIM, which protects LM-infected macrophages from apoptosis and promotes the killing of LM cells. These findings indicate distinct functions for LXR isoforms in macrophage antimicrobial activity and apoptosis.
Clearance of apoptotic cells by macrophages is essential for maintenance of the immune system. A-Gonzalez et al. recently showed that basal LXR-mediated signaling in macrophages is necessary for expression of mer receptor tyrosine kinase (Mer) which is crucial for clearance of apoptotic cells via phagocytosis (12) . LXRab -/-mice thus exhibit a selective defect in phagocytosis of apoptotic cells and bring about subsequent anomalous proinflammatory responses. Consequently, a breakdown in self-tolerance, production of autoantibodies, and development of autoimmune glomerulonephritis are observed in aging LXR-deficient mice. Figure 1 illustrates the roles of endogenous ligand-mediated LXR activation in macrophage function. In the next section, we introduce the molecular mechanisms responsible for LXRmediated gene activation and transrepression.
Mechanisms of LXR-mediated gene activation and transrepression
LXRs associate with retinoid X receptor (RXR). These heterodimers bind to specific DNA sequence, termed LXR response element, located in promoter regions of target genes such as ATP-binding cassette transporters. LXR response element consists of direct repeats of hexanucleotide (AGGT-CAN4AGGTCA) separated by four nucleotides (26, 27) . The heterodimers can be activated by ligands for LXRs or RXR (5). Activated-LXR:RXR heterodimer can act as transcriptional suppressors by co-operating with co-repressor complexes such as nuclear receptor co-repressor (NcoR) and silencing mediator of retinoic acid and thyroid hormone receptors (SMRT). Under inflammatory conditions, the corepressor complex is degraded via the proteasome pathway in the absence of LXR ligand. In the presence of LXR ligand, LXR is SUMOylated and protects the co-repressor complex from the proteasomal degradation system (28) . LXR-mediated stabilization of co-repressor complex results in repression of inflammatory gene expression.
LXRb-dependent regulation of murine T cell proliferation in response to antigens
It has been reported that some oxysterols, including 25-hydroxycholesterol effectively inhibit T cell proliferation in response to mitogenic or antigenic stimulation (29) (30) (31) . However, the reduced proliferative ability of T cells is not fully reversed by the addition of mevalonate, indicating that oxysterol-mediated inhibition of HMG CoA reductase also contributes to the inhibition of T cell proliferation. One recent study employing the synthetic LXR ligand T0901317 demonstrated that ligand-mediated LXR activation reduces T cell proliferation following antigen stimulation (32) . Together, these findings raise the possibility that LXR activation regulates the proliferative capacity of lymphocytes. Bensinger and colleagues reported that LXR signaling couples sterol homeostasis to antigen-specific T cell proliferation (6) . T cell activation induces expression of the oxysterolmetabolizing enzyme sulfotransferase (SULT)2B1, resulting in repression of LXR signaling leading to cholesterol efflux and upregulation of (sterol regulatory element binding protein) SREBP signaling which induces cholesterol synthesis (Figure 2) . SULT2B1 catalyzes the transfer of sulfate groups -/-T cells fail to proliferate following mitogenic stimulation. As mentioned in the introduction, murine T cells predominantly express LXRb. LXRb -/-mice, therefore, display lymphoid hyperplasia and enhanced responses to antigenic stimulation. Given that (i) murine B cell proliferation in response to antigenic stimulation is reduced in the presence of several synthetic LXR ligands or 22R-hydroxycholesterol (6) and (ii) older LXRab -/-mice exhibit a marked increase in the frequency and absolute numbers of CD19 q
B220
q B cells in their spleens and lymph nodes (12), it can be concluded that murine B cell proliferation is regulated by LXR signaling. In contrast, it has been reported that the proliferation of human and murine B cells induced by combined stimulation with anti-CD40 antibody and cytokines is not altered in the presence of T0901317 (9) . Further investigations will be required to elucidate the role of LXR activation in B cell proliferation in response to different stimuli.
A possible role for LXR activation in immunoglobulin production by B cells
The number of circulating auto-antibodies that recognize nuclear antigens (e.g., double-stranded DNA and histones) is drastically increased in older LXRab -/-mice. It seems that Together, these findings demonstrate that induced LXR signaling affects immunoglobulin production. Recently, the Russell group addressed the in vivo roles of endogenous 25-hydroxycholesterol in immunoglobulin secretion from murine B cells (34) . Cholesterol 25-hydroxylase-deficient mice exhibit a marked increase in serum IgA but not IgG1, IgG2b, IgG3, or IgM, demonstrating that 25-hydroxycholesterol negatively regulates IgA production. Treatment of splenic B cells with 25-hydroxycholesterol specifically inhibits IgA class switch recombination in response to costimulation with LPS, IL-5, and TGF-b1 by reducing the expression of activation-induced cytidine deaminase (AID) (Figure 3 ). Despite these findings, it is unclear whether LXR activation is responsible for 25-hydroxycholesterol-mediated suppression of IgA class switching for a few reasons. First, treatment of B cells with two other LXR-activating oxysterols, 22R-hydroxycholesterol and 24S-hydroxycholesterol, does not suppress IgA class switching (34) . Moreover, the synthetic LXR ligand T0901317 fails to repress AID expression or IgA production in murine B cells (9) . In vivo, macrophages are a major source of 25-hydroxycholesterol. Upon LPS stimulation, the expression of choles- terol 25-hydroxylase in macrophages is upregulated and newly synthesized 25-hydroxycholesterol is released from the cells (35) . Importantly, activation of innate immunity could increase de novo synthesis of 25-hydroxycholesterol, which in turn modulates the expression pattern of immunoglobulin isotypes in B cells.
LXR activation and dendritic cell-mediated antitumor immune response
Dendritic cells take up antigens and migrate into the draining lymphoid organs, where they prime naïve T cells to become effector T cells. In the case of antitumor immunity, killer T In addition, mice injected with tumor cells expressing SULT2B show reduced tumor growth, suggesting that SULT2B-sensitive oxysterols play an important role in the mechanism of tumor immunoescape.
Expert opinion and outlook
As reviewed above, naturally occurring LXR agonists such as oxysterols are essential for proper regulation of the immune system. We believe that these findings confer novel insights into functional relevance of lipid-mediated signaling and immune responses. We also discuss the potential value of artificial enhancement of LXR activation by oxysterols or synthetic ligands as a therapeutic strategy for treatment of immune diseases. In many animal models, administration of natural or synthetic LXR agonists results in the amelioration of glomerulonephritis (12) , allergic dermatitis (23, 37, 38) , experimental autoimmune encephalomyelitis (32, 39) , and type II collagen-induced arthritis (40) ( Table 2 ). Taken together, these studies raise the possibility that the regulation of LXR activation is a promising therapeutic target for treatment of these immune disorders. With regard to collageninduced arthritis, however, the opposite conclusion has been reached by other researchers (41) . Thus, further studies will be required to assess the therapeutic potential of LXR activation in autoimmune and inflammatory diseases. Additionally, the route of administration is crucial for the clinical application of LXR ligand because systemic administration of LXR ligands causes hypertriglycemia by inducing the expression of lipogenic genes in the liver (42) . The discovery of tissue-or cell-type specific LXR ligand wsuch as YT-32, a small intestine-selective LXR agonist (43)x will therefore prove the importance of LXR ligands as therapeutics. However, recent studies suggest that actions of LXR ligand differ between human and murine inflammatory responses (44, 45) . Unlike murine cells, LPS response in human macrophages and mature dendritic cells is enhanced by pretreatment with LXR ligand. In human cells, LXR activation results in enhancement of TLR4 expression and NF-kB signaling. Such species-specific regulation of gene expression is dependent on the presence of the LXR response element on the human TLR4 gene promoter. This element does not present in the promoter of the murine TLR4 gene. These findings clearly indicate complexity of LXR signaling. Thus, we consider that findings obtained from animal models need to be carefully assessed.
